Clinical Trials on Myotonic Dystrophy Type 2

Total 9554 results

Jeil Pharmaceutical Co., Ltd.

Not yet recruiting

Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

Korea, Republic of
Nanjing First Hospital, Nanjing Medical University

Recruiting

Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Sun Yat-sen University
The First Affiliated Hospital with Nanjing Medical University; Guangdong Provincial... and other collaborators

Completed

Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Bayer

Active, not recruiting

A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D) (START-AM)

Type 2 Diabetes Mellitus

India
Takeda

Completed

A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Shanghai HEP Pharmaceutical Co., Ltd.

Withdrawn

A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin

Type 2 Diabetes Patients
Nanjing First Hospital, Nanjing Medical University

Active, not recruiting

Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Handok Inc.

Completed

Tenelia Elderly CGMS Study(TEDDY)

Type 2 Diabetes Mellitus

Korea, Republic of
Rush University Medical Center

Withdrawn

Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit

Type 2 Diabetes Mellitus
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

Germany, United States, Spain, Poland
Ohio University

Withdrawn

WellStart Reboot Study

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan (LIXILAN JP-O2)

Type 2 Diabetes Mellitus

Japan
AstraZeneca

Completed

Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance

Type 2 Diabetes Mellitus

Korea, Republic of
Oramed, Ltd.
Integrium

Completed

Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus

Diabetes Type 2

United States
Antonio Di Mauro

Completed

GLP-1 and Oxyntomodulin Release in Relation to Diet in Type 2 Diabetes Patients. (VAS)

Type-2 Diabetes

Italy
Eli Lilly and Company

Completed

A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes (IMAGINE 8)

Type 2 Diabetes Mellitus

Germany, United States
University of Oxford
NIHR Collaboration for Leadership in Applied Health Research and Care (Oxford)

Completed

Type 2 Diabetes: Risk Perceptions and Self-management Behaviour

Type 2 Diabetes Mellitus

United Kingdom
Kun-Ho Yoon
Takeda

Completed

The Practical Evidence of Antidiabetic Combination Therapy in Korea (PEAK)

Type 2 Diabetes Mellitus

Korea, Republic of
Mitsubishi Tanabe Pharma Corporation

Completed

Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
KeyBioscience AG
Nordic Bioscience A/S

Completed

Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Denmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
Merck Sharp & Dohme LLC

Completed

A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)

Type 2 Diabetes Mellitus
University of Palermo
AstraZeneca; University of Catania

Unknown

Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes

Type 2 Diabetes Mellitus

Italy
LG Life Sciences

Completed

Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

Type 2 Diabetes Mellitus
AstraZeneca

Completed

Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Type 2 Diabetes Mellitus

China
Biocon Limited

Completed

Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD

Type 2 Diabetes Mellitus
Sun Yat-sen University

Suspended

Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus
Novartis Pharmaceuticals

Completed

Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin

Type-2 Diabetes Mellitus

Hong Kong
Dong-A ST Co., Ltd.

Completed

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Type 2 Diabetes Mellitus

Korea, Republic of
Novartis

Completed

Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy

Type 2 Diabetes Mellitus

China
Takeda

Terminated

Fasiglifam 25 mg BID vs 50 mg QD

Type 2 Diabetes Mellitus

United States, Poland, Ukraine, Taiwan, Bulgaria, Romania, Slovakia
Takeda

Completed

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"

Type 2 Diabetes Melitus
HealthPartners Institute
Amylin Pharmaceuticals, LLC.

Completed

Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide

Type 2 Diabetes Mellitus

United States
University of Arizona

Unknown

Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes (MET)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)

Type 2 Diabetes Mellitus
Poxel SA

Completed

A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Latvia
Pusan National University Hospital

Unknown

Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin

Type 2 Diabetes Mellitus

Korea, Republic of
AstraZeneca
Eli Lilly and Company

Completed

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

Type 2 Diabetes Mellitus

United States, Mexico, India
AstraZeneca
Eli Lilly and Company

Completed

Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Hospital Universitario Central de Asturias
Sanofi

Terminated

Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study) (PININ)

Type 2 Diabetes Mellitus
Charles Drew University of Medicine and Science
National Center for Research Resources (NCRR)

Completed

Sitagliptin in Combination With Metformin and Sulfonylurea

Type 2 Diabetes Mellitus

United States
Endocrine Research Society

Suspended

Comparing Internet Blood Glucose Monitoring System and Continuous Glucose Monitoring System

Type 2 Diabetes Mellitus

Canada
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Poland, United Kingdom, Germany, Romania, Hungary, Denmark, Lithuania
Novartis Pharmaceuticals

Completed

Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
University Hospital, Toulouse

Completed

Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes

Type 2 Diabetes Mellitus

France
Novartis Pharmaceuticals

Completed

Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan (STEADFAST)

Type 2 Diabetes Mellitus

Egypt, United Kingdom, Turkey, Lebanon, Russian Federation, Tunisia, Malaysia, Germany, Spain, Saudi Arabia, Denmark, Indonesia, Jordan, Kuwait, Singapore, United Arab Emirates
Sanofi

Completed

Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy (Insuman-C25-CN)

Type 2 Diabetes Mellitus

China
Maastricht University Medical Center

Unknown

Nitrate and Exercise-induced Cardiac Troponin T in Type 2 Diabetes (NO troponin)

Type 2 Diabetes Mellitus

Netherlands
Takeda

Completed

Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Tehran University of Medical Sciences

Completed

Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

Iran, Islamic Republic of

3

Subscribe